Skip to main content
BODI logo

BODI · Beachbody Company, Inc.

Track BODI — free
$2.62 -0.18 (-6.43%) At close · Nov 20
Market Cap
$19.14M
Shares
7.31M
Volume · Nov 20 41.19K Avg daily vol (3M) 29.63K

Price & Indicators

 

Key stats

Close
$2.62
Fri 20 Nov
Open
$2.80
Fri 20 Nov
Average volume, 30 days
29K
shares a session
Short interest
177K
2.4% of shares · 12.7 days to cover
Day range
$2.57$2.89
Open $2.80 Close $2.62
52-week closing range
$2.62$16.05
Close $2.62 83.7% under the high
Short volume, last session
14%
Last earnings
Nov 10, 2026
Latest filing
10-Q · Nov 10
Price history
Jan 2021 to Nov 2026

Up next

Mar 9, 2027 Est · unconfirmed · in 15 wks

Latest documents

2026
Nov 10
Earnings call
Q3 revenue $45.2 million, adjusted EBITDA $6.4 million above guidance

Beachbody third-quarter revenue was $45.2 million, adjusted EBITDA $6.4 million above the $3 to $6 million guidance range, and net income $3.3 million — a 12th consecutive quarter of positive adjusted EBITDA. Q4 guidance is $38 million to $42 million.

5 source passages
Total revenue for the third quarter was $45.2 million within our guidance range of $44 to $48 million. Adjusted EBITDA was $6.4 million, above the high end of our guidance range of $3 to $6 million. I want to point out, this was our 12th consecutive quarter of positive adjusted EBITDA Operating income was $1.3 million, and net income was $3.3 million, both above the high end of our guidance range. We expect fourth quarter revenues to be in the range of $38 million to $42 million Open the document at this passage
Nov 10
Quarterly report 10-Q FY2026 Q3, ended Sep 30
Revenue falls 25% amid nutrition-focused restructuring

The Beachbody Company, Inc. reported a 25% revenue decline to $45.2 million while net income reached $3.3 million. Its Nutrition Restructuring will cut approximately 80 employees, about 31% of its workforce, and cost approximately $3.0 million.

Revenue $45.19M ▼ 24.5% Net income $3.28M ▼ 8.1% Diluted EPS $0.38 ▼ 25.5%
Read from the MD&A section
4 source passages
Unless otherwise indicated, the terms “BODi,” “we,” “us,” or “our” refer to The Beachbody Company, Inc., a Delaware corporation, together with its consolidated subsidiaries. Total revenue was $45.2 million, a 25% decrease; Net income was $3.3 million, the Company's fifth consecutive quarter of net income, compared to a net income of $3.6 million; On October 6, 2026, the Company executed a restructuring (the "Nutrition Restructuring") primarily related to the Company's shift in focus from digital to nutrition which will reduce the Company's headcount by approximately 80 employees (approximately 31% of the Company's workforce on that date) in the fourth quarter of 2026. The actions associated with the Nutrition Restructuring are expected to result in approximately $3.0 million in costs and payments consisting primarily of termination benefits during the fourth quarter of 2026. Open the document at this passage
Nov 10
Current report 8-K
Revenue falls as free cash flow turns negative

The Beachbody Company, Inc. reported third-quarter revenue of $45.2 million and net income of $3.3 million. Adjusted EBITDA was $6.4 million, while nine-month free cash flow was $(12.1) million.

Financial results
5 source passages
The Beachbody Company, Inc. (NASDAQ: BODi) (“BODi” or the “Company”), the proactive wellness company delivering nutrition, supplements, and proven fitness programs that help people take control of their health inside and out, today announced financial results for its third quarter ended September 30, 2026. Total revenue was $45.2 million compared to $59.9 million in the prior year period. Net income was $3.3 million, the Company's fifth consecutive quarter of net income, compared to $3.6 million in the prior year period. Adjusted EBITDA1 was $6.4 million compared to $9.5 million in the prior year period. Free cash flow1 was $(12.1) million compared to $13.1 million in the prior year period. Open the document at this passage
Aug 10
Quarterly report 10-Q FY2026 Q2, ended Jun 30
Quarterly report for FY2026 Q2 AI summary on its way
Revenue $49.61M ▼ 22.4% Net income $1.38M Diluted EPS $0.11
All documents

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$204.62M
Trailing 12 months
Net income (TTM)
$12.17M
Trailing 12 months
Revenue growth YoY
-24.5%
Year over year
Operating margin
7.0%
Trailing 12 months
P / E (TTM)
1.7
Trailing earnings · reciprocal yield 59.5%
FCF yield
-41.1%
TTM · current market cap
Return on invested capital
37.4%
Trailing 12 months
Net cash
$4.64M
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+5.3%
Year over year · more shares
Price change (1Y)
-66.9%
Trailing year
Short interest
2.4%
Latest settlement · 12.7 days to cover
View all 125 metrics

AI Brief

Q3 FY26 earnings call · Nov 10, 2026
Q3 FY26

TL;DR. BODi exceeded its third-quarter adjusted EBITDA, operating income, and net income guidance, reduced operating expenses, and anticipates $34 million of 2027 spending reductions and a lower breakeven point. However, revenue, subscriptions, gross margin, adjusted profitability, and free cash flow declined, the growth turnaround remains delayed by customer attrition and retail planogram timing, and fourth-quarter guidance includes a possible net loss and approximately $3 million of restructuring expense.

Bullish
  • + Third-quarter adjusted EBITDA, operating income, and net income exceeded the high end of guidance.
  • + The company anticipates $34 million of 2027 spending reductions and a lower adjusted EBITDA breakeven point.
  • + Moving supplement manufacturing to partners is expected to improve production speed, reduce inventory, and preserve liquidity.
Bearish

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Strong Sell Momentum Very Weak Sentiment Bearish Fundamentals Excellent Quant / Vol Very High
Market backdrop VIX 35.9 · fear Equity put/call 0.77
Technical
price trend
Strong Sell
50 / 200-day cross No cross
Price vs 200-day avg −70%
below
Price vs 50-day avg −40%
below
RSI (14) 21
oversold
MACD trend Negative
52-week position 0%
near low
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Weak
1-month return −38%
trailing
6-month return −76%
trailing
YTD return −75%
this year
Relative strength −67%
vs S&P · 6-mo
Sentiment
smart money
Bearish
Trend (MA cross) No cross
50d $4 › 200d $9 — 200d above 50d
Institutional flow Distributing
-16% holders QoQ · +4 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
2.42% of shares out · ▲ +0.6% MoM · 12.7 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
49 holders — mid 3-yr range
Squeeze score 54
elevated · 0–100
Fundamentals
Excellent
Revenue growth −40%
Y/Y
Gross margin 73%
expanding
EPS growth +96%
Y/Y
Free cash flow $17.4M
Balance sheet $15.4M
net cash
Quant / Vol
risk profile
Very High
Volatility 95%
annualized · 1-yr
Max drawdown −84%
past year
ATR 13.8%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Beat or met 8 of last 8
Latest guidance · from the Earnings Call filed Nov 10, 2026
Q4
Restructuring expense $3M
Digital 64%
Nutrition 36%
fourth quarter
Revenues $38M – $42M
prior qtr $45.19M midpoint −11.5% QoQ
Adjusted EBITDA Non-GAAP $6M – $9M
the quarter
Digital 64%
Nutrition and other 36%
Nutrition and other gross margin 41% – 44%
Digital gross margin 86% – 88%
Total gross margin 68% – 70%
2027
2027 anticipated overhead $27M
Overall spending reduction $34M
Prior guidance period ended · from the Earnings Call filed Aug 10, 2026
Revenues · third quarter $44M – $48M
Adjusted EBITDA · third quarter $3M – $6M
Digital gross margin target · third quarter 86% – 88%
Nutrition and other gross margin target · third quarter 42% – 45%
Total gross margin target · third quarter 68% – 71%
Digital growth margin target · third quarter 86% – 88%
Guided vs delivered · last 8 settled
Revenues third quarter
guided $44M – $48M
$45.19M In line
Revenue Outlook For Quarter Ending June 30, 2026
guided $46M – $51M
$49.61M In line
First quarter revenues first quarter 2026
guided $49M – $54M
$54.28M Beat +5.4%
Revenue Outlook For Quarter Ending December 31, 2025
guided $50M – $57M
$55.54M In line

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Strong Sell
4 · 3 · 0
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−70% Bearish
Price vs 50-day avg
−40% Bearish
RSI (14)
21 Neutral
MACD trend
Negative Bearish
52-week position
0% Bearish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross) No cross
50d $4 › 200d $9 — 200d above 50d
Institutional flow Distributing
-16% holders QoQ · +4 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
2.42% of shares out · ▲ +0.6% MoM · 12.7 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
49 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $3 Now $3 · 0% Range high $16
vs 200-day avg -70% vs 50-day avg -40%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
Digital 86.3% the three months ended September 30, 2026 filing —
Free cash flow non-GAAP -$12.1M Nine Months Ended September 30, 2026 —
Net cash position non-GAAP $4.64M As of September 30, 2026 —
Nutrition and other 45.8% the three months ended September 30, 2026 filing —
Total gross margin 70.7% the three months ended September 30, 2026 filing —

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Internet Content & Information — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
BODI
Beachbody Company, Inc.
this stock
$19.14M -74.7% -39.9% — 2.4%
GOOGL
Alphabet Inc.
$3.26T -15.2% +15.1% 13.9 0.7%
META
Meta Platforms, Inc.
$1.43T -15.0% +47.1% 19.1 3.0%
SPOT
Spotify Technology S.A.
$118.59B -0.6% — — 1.5%
NBIS
Nebius Group N.V.
$23.82B -2.9% +479.0% — 17.4%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
49
% held
19.7%
Net QoQ
-303.8K sh
Top holder
Raine Capital LLC
Held Float
View
Held by Funds
Fund positions
25
View
Short & Settlement
Short Interest Rising
Shares short
176.9K
Days to cover
12.7d
Change
+1.1K sh
View
Short Volume
Short vol %
14%
As of
Nov 20, 2026
Short Total
View
Fails to Deliver
FTD shares
162
Value
$695
As of
Oct 30, 2026
View
Off-Exchange
Off-exchange %
34.9%
Week of
Oct 12, 2026
Off-exch Lit
View
Financials
Financials
Revenue (FY)
$251.7M
Net income (FY)
$-2.9M
EPS diluted
$-0.41
View
Filings
SEC Filings
Latest
8-K
Filed
Nov 10, 2026
This year
15

The Beachbody Company, Inc. reported third-quarter revenue of $45.2 million and net income of $3.3 million. Adjusted EBITDA was $6.4 million, while nine-month free cash flow was $(12.1) million.

View
Earnings & Events
Webcasts
Last webcast
Nov 10, 2026
View
Investor Relations
Latest news
BODi Unleashes Brand New “INSANIT…
Published
Nov 13, 2026
View

Performance

5D 20D 120D MTD YTD
BODI -22.6% -38.4% -75.9% -37.0% -74.7%
SPY -8.6% -9.2% -9.2% -8.7% +1.2%
vs SPY -14.0% -29.1% -66.8% -28.3% -75.9%
Key facts CIK 1826889 CUSIP 073463309 13F (30d) 51 filings 47 filers Visit website Investor relations